Loading...
Re-challenge chemotherapy in patients with sensitive relapse small-cell lung cancer and interstitial lung disease
BACKGROUND: Treatment modalities for small-cell lung cancer (SCLC) with pre-existing interstitial lung disease (ILD) are limited. Although re-challenge with first-line chemotherapy can be effective for sensitive relapse SCLC, its safety and efficacy are uncertain in cases with ILD. This study aimed...
Na minha lista:
| Udgivet i: | J Thorac Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6409263/ https://ncbi.nlm.nih.gov/pubmed/30962995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.01.26 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|